RESEARCH TRIANGLE PARK, N.C.--()--Kinetigen, Inc., a specialty pharmaceutical consulting firm with global reach, will be exhibiting and sharing its in-depth knowledge of how to use Pharmacokinetics (PK) more efficiently at the American Society for Clinical Pharmacology and Therapeutics (ASCPT) Annual Meeting in Indianapolis, March 5-8.
“Kinetigen aims to actively reduce risk in drug development and increase the value of clinical pharmacology and PK investigations by applying proven strategies.”
Pharmacokinetics is about capturing the right information at the right time, yet insufficient planning, execution and analysis around PK can lead to poor data, adding costs and delays to drug development. Kinetigen specializes in translating complex PK issues into robust and actionable advice for rational drug development. Accordingly, companies are realizing cost-effective results by our consultants providing the right mix of substance and usability in pharmacokinetics.
“Kinetigen’s dedication to excellence in pharmacokinetics continues to pay dividends for our clients,” said Geoffrey Banks, Ph.D., company CEO. “We look forward to sharing our vision with attendees at ASCPT about how pharmacokinetic analyses can be conducted to save time and money in drug development,” he explained.
Kinetigen’s focus on PK means that its team of industry-leading consultants provides better interpretation of PK data and superior advice for clients, Dr. Banks explained, “Kinetigen aims to actively reduce risk in drug development and increase the value of clinical pharmacology and PK investigations by applying proven strategies.”
About Kinetigen, Inc.
Kinetigen, Inc. is a clinical pharmacology consulting firm specializing in pharmacokinetics. Fast becoming the pharmaceutical industry’s go-to resource for pharmacokinetics, Kinetigen gives pharmaceutical companies and CROs rare access to a hands-on team of leading clinical pharmacology and pharmacokinetics professionals experienced in many different therapeutic areas. We embrace the notion that simplicity and clarity lead to good decisions by taking complex pharmacokinetic principals and making them understandable and usable for common sense drug development. Kinetigen’s flexible business structure enables us to integrate with our clients and help them maximize the potential of clinical pharmacology studies and pharmacokinetics analyses to pave the way toward marketing approval.
For more information visit www.kinetigen.com.